MALMEDIS - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 3,107,257 | 1,713,042 | 1,527,461 | 1,651,678 | 2,443,565 | 1,698,578 | 1,648,336 | 1,619,878 |
| Profit before tax | -29,608 | -212,145 | -110,286 | -34,596 | -3,115 | 4,734 | 79,979 | -34,860 |
| Net profit | -29,608 | -212,145 | -110,286 | -34,596 | -3,115 | 4,734 | 79,979 | -34,860 |
| Equity | 360,095 | 147,951 | 37,665 | 51,085 | 47,971 | 52,704 | 132,682 | 97,825 |
| Liabilities | 815,852 | 853,840 | 678,644 | 665,479 | 404,233 | 273,151 | 248,883 | 402,769 |
| Non-current assets | 926,055 | 811,539 | 540,555 | 418,346 | 272,852 | 225,224 | 329,804 | 293,033 |
| Current assets | 249,892 | 190,252 | 175,754 | 298,218 | 179,352 | 100,631 | 51,761 | 207,561 |
| Total assets | 1,175,947 | 1,001,791 | 716,309 | 716,564 | 452,204 | 325,855 | 381,565 | 500,594 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 271,513 | 214,440 | 282,515 |
| Social insurance contributions | - | - | - | - | - | 89,208 | 88,606 | 98,815 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +3.0% | -44.9% | -10.8% | +8.1% | +47.9% | -30.5% | -3.0% | -1.7% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -2.5% | -21.2% | -15.4% | -4.8% | -0.7% | 1.5% | 21.0% | -7.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -8.2% | -143.4% | -292.8% | -67.7% | -6.5% | 9.0% | 60.3% | -35.6% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -1.0% | -12.4% | -7.2% | -2.1% | -0.1% | 0.3% | 4.9% | -2.2% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -1.0% | -12.4% | -7.2% | -2.1% | -0.1% | 0.3% | 4.9% | -2.2% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 2.3 | 5.8 | 18.0 | 13.0 | 8.4 | 5.2 | 1.9 | 4.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 98,905 | 56,474 | 53,129 | 60,244 | 88,589 | 63,697 | 62,006 | 63,112 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
MALMEDIS - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-07-31 | 2026-08-03 | 6.15 |
| 2026-07-27 | 2026-07-30 | 822.49 |
| 2026-05-17 | 2026-05-17 | 7662.88 |
| 2026-05-03 | 2026-05-06 | 2.11 |
| 2026-04-23 | 2026-04-29 | 2.11 |
| 2025-10-23 | 2025-11-13 | 2.24 |
| 2025-07-24 | 2025-07-28 | 4.38 |
| 2025-04-24 | 2025-04-27 | 4.10 |
| 2024-04-23 | 2024-05-12 | 6.30 |
| 2024-02-23 | 2024-02-25 | 10.87 |
| 2023-12-18 | 2023-12-18 | 7306.65 |
| 2023-11-08 | 2023-11-14 | 6.71 |
| 2023-09-19 | 2023-10-16 | 0.01 |
| 2023-05-02 | 2023-05-15 | 2.65 |
| 2023-04-25 | 2023-04-28 | 2.65 |
| 2023-01-19 | 2023-01-19 | 6823.44 |
| 2023-01-17 | 2023-01-18 | 6872.47 |
| 2022-12-16 | 2022-12-19 | 3000.00 |
| 2022-07-25 | 2022-08-09 | 6.19 |
| 2022-06-17 | 2022-06-19 | 2927.35 |
| 2022-06-16 | 2022-06-16 | 5927.35 |
| 2022-01-28 | 2022-02-01 | 3.26 |
| 2021-12-16 | 2021-12-16 | 5440.21 |
MALMEDIS - VMI tax arrears
As of 2026-09-02, the amount of overdue STI tax debt of the company MALMEDIS is: 6 €
| From | To | Overdue, € |
|---|---|---|
| 2026-08-31 | 2026-09-02 | 5.57 |
| 2026-08-30 | 2026-08-30 | 5.58 |
| 2026-08-12 | 2026-08-13 | 4796.82 |
| 2026-08-02 | 2026-08-11 | 5.3 |
| 2026-06-30 | 2026-07-07 | 4.16 |
| 2026-05-17 | 2026-05-18 | 33.41 |
| 2026-05-13 | 2026-05-16 | 10179.34 |
| 2026-04-30 | 2026-05-12 | 13.62 |
| 2026-03-19 | 2026-03-24 | 0.04 |
| 2026-03-17 | 2026-03-17 | 11.28 |
| 2026-03-16 | 2026-03-16 | 7.12 |
| 2026-03-13 | 2026-03-15 | 7.28 |
| 2026-03-11 | 2026-03-12 | 4019.27 |
| 2026-03-08 | 2026-03-10 | 4012.15 |
| 2026-02-21 | 2026-02-21 | 0.12 |
| 2026-02-18 | 2026-02-20 | 4492.14 |
| 2026-02-16 | 2026-02-17 | 4487.5 |
| 2026-02-03 | 2026-02-16 | 2.76 |
| 2026-01-16 | 2026-01-19 | 4701.98 |
| 2026-01-08 | 2026-01-15 | 4683.68 |
| 2025-12-18 | 2025-12-29 | 6.18 |
| 2025-11-30 | 2025-12-05 | 11.74 |
| 2025-11-28 | 2025-11-29 | 22595.57 |
| 2025-11-18 | 2025-11-27 | 4.7 |
| 2025-10-16 | 2025-10-20 | 16.89 |
| 2025-09-23 | 2025-10-15 | 0.01 |
| 2025-07-30 | 2025-07-31 | 6.05 |
| 2025-07-29 | 2025-07-29 | 22434.15 |
| 2025-07-28 | 2025-07-28 | 22416.0 |
| 2025-07-13 | 2025-07-22 | 10.46 |
| 2025-07-04 | 2025-07-20 | 5.43 |
| 2025-07-11 | 2025-07-12 | 0.06 |
| 2025-07-03 | 2025-07-03 | 383.08 |
| 2025-07-01 | 2025-07-02 | 1.08 |
| 2025-06-18 | 2025-06-18 | 13.77 |
| 2025-05-30 | 2025-06-05 | 9.05 |
| 2025-05-29 | 2025-05-29 | 4007.97 |
| 2025-05-17 | 2025-05-28 | 6.7 |
| 2025-04-30 | 2025-05-16 | 11.48 |
| 2025-04-28 | 2025-04-29 | 14179.99 |
| 2025-04-04 | 2025-04-14 | 1857.81 |
| 2025-03-22 | 2025-03-27 | 0.06 |
| 2025-03-20 | 2025-03-21 | 3.38 |
| 2025-03-16 | 2025-03-17 | 3102.64 |
| 2025-03-15 | 2025-03-15 | 3091.02 |
| 2025-02-21 | 2025-02-26 | 0.9 |
| 2025-02-20 | 2025-02-20 | 0.02 |
| 2024-10-15 | 2024-10-16 | 10.92 |
| 2024-10-10 | 2024-10-14 | 2694.28 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
MALMEDIS, UAB (code 183216169) is a Private Limited Liability Company engaged in freight transport by road. In 2025, the company generated revenue of €1.62M, slightly below €1.65M in 2024 and €1.70M in 2023, showing a modest decline over the three-year period. After a strong 2024 result of €80.0K net profit, 2025 ended with a net loss of €34.9K and a profit margin of -2.2%. The latest year also shows weaker returns, with ROE at -35.6% and ROA at -7.0%. At the same time, asset use remained active, with asset turnover at 3.24x and revenue per employee at €64.8K.
The balance sheet expanded in 2025: total assets reached €500.6K, compared with €381.6K in 2024 and €325.9K in 2023. Equity stood at €97.8K, while liabilities increased to €402.8K, resulting in a debt-to-equity ratio of 4.12 and an equity ratio of 19.5%. Long-term assets were €293.0K and short-term assets €207.6K.
The balance sheet expanded in 2025: total assets reached €500.6K, compared with €381.6K in 2024 and €325.9K in 2023. Equity stood at €97.8K, while liabilities increased to €402.8K, resulting in a debt-to-equity ratio of 4.12 and an equity ratio of 19.5%. Long-term assets were €293.0K and short-term assets €207.6K.